Researchers report disappointing results about ovarian cancer screening, and cancer patients with impaired immune function feel uncertain about protection offered by COVID-19 vaccination.

by Marci A. Landsmann

Advances in screening and treatment mean there are more cancer survivors than ever, but survivors who struggle to work can face difficulty getting disability payments.

by Jen Tota McGivney

At a patient advocate event, researchers discussed how to extend the benefits of immunotherapy to more people.

by Kevin McLaughlin

A Food and Drug Administration panel recommends withdrawing approvals for two treatment indications for immunotherapy drugs, and the U.S. Preventive Services Task Force recommend against vitamin E and beta-carotene for cancer prevention.

by Kevin McLaughlin

Testing children with cancer for hereditary mutations could impact their treatment and provide information relevant to other family members.

by Marcus A. Banks

President Biden resurfaces a proposal for a new health care agency, and the Food and Drug Administration approves a treatment for large B-cell lymphoma.

by Bradley Jones

Researchers are investigating who is at greatest risk for radiation-induced cancers.

by Kate Yandell

For people with melanoma who receive immune checkpoint inhibitors after surgery, side effects can remain even after treatment has been completed. These chronic side effects are most often mild.

by Anna Goshua

Anti-racism activist and historian Ibram X. Kendi opens up about his stage IV colon cancer treatment, and the FDA approves an immunotherapy drug for endometrial cancer

by Marci A. Landsmann

Attending a scientific conference as a patient advocate can be an exhausting, overwhelming and hugely rewarding experience.

by Bradley Jones